CROSS COUNTRY HEALTHCARE INC CCRN

Rank #38 · Nasdaq · $0.4B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

81.2

P/E

5.9

P/B

0.95

ROE

16.1%

Op. Margin

5.6%

Debt Ratio

38%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★★

Excellent

P/E 5.9x, P/B 0.95x. Ranks in the top 7% of the universe.

Profitability ★★★☆☆

Average

ROE 16.1%. Ranks in the top 43% of the universe.

Safety ★★★★☆

Excellent

Debt ratio 38%. Ranks in the top 20% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆

Poor

Revenue decline of 28.0% year over year. Ranks in the top 94% of the universe.

Valuation is the relative strength · Growth is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2011	–	$0.0B	$0.0B	$0.2B	–	42
2012	–	$-0.0B	$-0.0B	$0.2B	–	40
2013	–	$0.0B	$0.0B	$0.2B	–	39
2014	–	$-0.0B	$-0.0B	$0.2B	–	55
2015	–	$-0.0B	$-0.1B	$0.1B	–	150
2016	–	$-0.0B	$-0.0B	$0.1B	–	159
2017	–	$0.0B	$0.0B	$0.2B	–	156
2018	$0.8B	$0.0B	$0.0B	$0.2B	0.7	97
2019	$0.9B	$0.0B	$0.0B	$0.2B	1.4	96
2020	$0.8B	$-0.0B	$-0.0B	$0.2B	-1.6	135
2021	$0.8B	$-0.0B	$-0.1B	$0.2B	-1.9	131
2022	$0.8B	$-0.0B	$-0.0B	$0.3B	-1.1	146
2023	$1.7B	$0.1B	$0.1B	$0.5B	8.3	107
2024	$2.8B	$0.3B	$0.2B	$0.3B	9.6	169
2025	$2.0B	$0.1B	$0.1B	$0.5B	5.6	38